These original manuscripts highlight diverse, ongoing, and promising research efforts and applications with a special focus on novel methods and devices that are aimed to prevent, diagnose, or treat a wide range of cancers (brain, breast, esophagus, pancreas, colon, skin) with minimal or no associated morbidity. They report exciting results in areas such as detecting invasive brain cancer cells by coupling artificial neural networks with Raman spectroscopy (Jermyn et al.) , distinguishing between malignant and benign lesions in breast cancer by using diffuse optical spectroscopic imaging (Leproux et al.) , screening for Barrett's esophagus by using optical coherence tomography in primary care practice (Gora et al.) , or performing laser speckle-based point-ofcare measurements of blood flow (Farraro et al.) . The authors address key aspects involved in navigating the translational pipeline, such as identifying clinical problems and unmet clinical needs, describing barriers to clinical translation, disseminating and adopting new technologies, and developing sound measures to assess efficacy.
The commentary paper (Tromberg et al.) identifies common essential features for successful translation by examining the origins and critical paths of three major international academic affiliated centers, founded mid-late 1970s.
The objective of both the symposium and this series is to enable a new generation of biomedical scientists to pursue translational research careers, to encourage the emergence and growth of successful translation-oriented initiatives that will not only sustain, but also further increase the impact of biophotonics and biomedical optics on human health.
The guest editors would like to thank all authors for their excellent contributions as well as the reviewers from all over the world for their high-quality work and commitment to making this special series a success. The guest editors would also like to express their gratitude to Lihong Wang, editor-inchief of JBO, for giving our community this unique opportunity; Gwen Weerts, managing editor for SPIE journals for her continuous support and attention; and the JBO staff who helped complete this series every step of the way. Conor L. Evans, PhD, is an assistant professor at Harvard Medical School and runs a research laboratory at the Wellman Center for Photomedicine dedicated to the development and translation of optical technologies for disease diagnostics and therapeutics. His research interests include the development of advanced microscopy technologies to investigate and follow treatment response, oxygensensing "smart" bandage technologies, and ultrasensitive detection methods for cancer diagnostics and immunoncology.
Kristen M. Kelly, MD, is a professor of dermatology and surgery at the University of California, Irvine, and vice-chair of the UC Irvine Department of Dermatology. She has more than 20 years of experience in basic science and clinical translational research focusing on development and use of light-based technologies for diagnosis and treatment of disease, especially cutaneous vascular lesions and skin cancer.
Bruce J. Tromberg, PhD, is a professor of biomedical engineering and surgery at the University of California, Irvine (UCI), and director of UCI's Beckman Laser Institute and Medical Clinic. He has more than 25 years of experience in the development of optics and photonics technologies and their application to biology and medicine. His research interests are in the development of quantitative broadband biophotonics technologies for characterizing and imaging tissue structure, function, and composition across spatial scales.
